Cargando…

Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher

Background and Aims: Utilization of living donor liver transplantation (LDLT) and its relationship with recipient Model for End-Stage Liver Disease (MELD) needs further evaluation in the United States (U.S.). We evaluated the association between recipient MELD score at the time of surgery and surviv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perumpail, Ryan B., Yoo, Eric R., Cholankeril, George, Hogan, Lupe, Deis, Melodie, Concepcion, Waldo C., Bonham, C. Andrew, Younossi, Zobair M., Wong, Robert J., Ahmed, Aijaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075001/ https://www.ncbi.nlm.nih.gov/pubmed/27777886 http://dx.doi.org/10.14218/JCTH.2016.00029

Ejemplares similares

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation
por: Cholankeril, George, et al.
Publicado: (2019)

Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States
por: Siddique, Osama, et al.
Publicado: (2017)

Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era
por: Li, Andrew A., et al.
Publicado: (2018)

Trends in Liver Transplantation in Hepatitis C Virus–Infected Persons, United States
por: Perumpail, Ryan B., et al.
Publicado: (2016)

Sofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United States
por: Jayasekera, Channa R., et al.
Publicado: (2017)

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome
por: Yoo, Eric R., et al.
Publicado: (2016)

The importance of a multidisciplinary approach to hepatocellular carcinoma
por: Siddique, Osama, et al.
Publicado: (2017)

Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis
por: Perumpail, Brandon J., et al.
Publicado: (2017)

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease
por: Perumpail, Brandon J., et al.
Publicado: (2017)

Expanding Treatment Access for Chronic Hepatitis C with Task-shifting in the Era of Direct-acting Antivirals
por: Yoo, Eric R., et al.
Publicado: (2017)

Hepatic encephalopathy: what the multidisciplinary team can do
por: Liu, Andy, et al.
Publicado: (2017)

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
por: Perumpail, Brandon J, et al.
Publicado: (2017)

Recent advances in liver transplantation with HCV seropositive donors
por: Murag, Soumya, et al.
Publicado: (2019)

MELD-GRAIL and MELD-GRAIL-Na Are Not Superior to MELD or MELD-Na in Predicting Liver Transplant Waiting List Mortality at a Single-center Level
por: Chetwood, John D., et al.
Publicado: (2022)

Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents
por: Cholankeril, George, et al.
Publicado: (2017)

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018)

Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic
por: Kim, Donghee, et al.
Publicado: (2021)

Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care
por: Younossi, Zobair M., et al.
Publicado: (2016)

Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and Nonalcoholic Steatohepatitis-Related Liver Disease
por: Cholankeril, George, et al.
Publicado: (2017)

Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States
por: Stepanova, Maria, et al.
Publicado: (2017)

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
por: Montano-Loza, Aldo J, et al.
Publicado: (2015)

HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST
por: NACIF, Lucas Souto, et al.
Publicado: (2018)

Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience
por: Aggarwal, Avin, et al.
Publicado: (2017)

Liver Transplantation in Patients with Portal Vein Thrombosis: Comparing Pre-MELD and MELD era
por: Saidi, R. F., et al.
Publicado: (2012)

Revising the MELD Score to Address Sex-Bias in Liver Transplant Prioritization for a German Cohort
por: Walter Costa, Maria Beatriz, et al.
Publicado: (2023)

Judicious Use of Lipid Lowering Agents in the Management of NAFLD
por: Iqbal, Umair, et al.
Publicado: (2018)

The Usefulness of Mayo End-stage Liver Disease (MELD) and MELD-Sodium (MELD-Na) Scores for Predicting Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
por: Coxeter-Smith, Catherine, et al.
Publicado: (2023)

Clozapine is underutilized
por: Kane, John M.
Publicado: (2012)

Invited response to “MELD calibration”
por: Goudsmit, Ben F. J., et al.
Publicado: (2020)

Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor
por: Stepanova, Maria, et al.
Publicado: (2016)

Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality
por: Golabi, Pegah, et al.
Publicado: (2019)

MELD-GRAIL-Na Is a Better Predictor of Mortality Than MELD in Korean Patients with Cirrhosis
por: Kim, Jung-Woo, et al.
Publicado: (2023)

The Role of Vitamin E in the Treatment of NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2018)

When to Initiate Weight Loss Medications in the NAFLD Population
por: Yoo, Eric R., et al.
Publicado: (2018)

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2019)

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2018)

Bias Adjustment Techniques Are Underutilized in HIV Sexual Risk Estimation: A Systematic Review
por: Tran, Nguyen K., et al.
Publicado: (2018)

MELD-Sarcopenia is Better than ALBI and MELD Score in Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
por: Alsebaey, Ayman, et al.
Publicado: (2021)

MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement
por: Krishnan, Arunkumar, et al.
Publicado: (2023)

Living-Donor Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Score and Predictive Value of NLR on Survival
por: Hung, Hao-Chien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8e163u0n7eeqa2k4cpid9mk5or